Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Old versus young comparison of losartan and perindopril exposure in hypertension
NL-OMON52352Terminated
- Sponsor
- Erasmus MC
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of losartan and perindopril in hypertension (HTN) (5 arms), sponsored by Erasmus MC. Primary endpoint: Difference in exposure to losartan and perindopril by age group. Started Feb 2021; status: terminated.
02
Drugs
losartanperindopril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NL-OMON52352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52352.